VIM and colorectal carcinoma: A panel of 80 methylation markers including SEPT9, IKAROS family zinc finger 1 (IFZF1), Branched chain amino acid transaminase 1 (BCAT1), vimentin (VIM), and others, displayed a sensitivity of 74% and a specificity of 90% for identifying early-stage CRC [69].